3′-Deoxy-3′-18F-fluorothymidine (18F-FLT) is a recently developed PET tracer to image
tumor cell proliferation. We characterized 18F-FLT PET of brain gliomas and compared 18F …

Abstract The aim of this study was to evaluate the feasibility of using [18 F] 3′-deoxy-3′-
fluorothymidine (FLT) positron emission tomography (PET) for the diagnosis and grading of …

The purpose of this study was to compare the diagnostic value of positron emission
tomography (PET) using [18F]-fluorodeoxyglucose (18F-FDG) and O-(2-[18F] fluoroethyl)-l …

Purpose 18 F-labeled deoxy-fluorothymidine (FLT), a marker of cellular proliferation, has
been used in PET tumor imaging. Here, the FLT kinetics of malignant brain tumors were …

Abstract In recent years,[18 F]-fluoro-3′-deoxy-3′-L-fluorothymidine ([18 F] FLT) has been
developed as a proliferation tracer. Imaging and measurement of proliferation with PET …

Here we describe the evaluation of 3′-[18F] fluoro-3′-deoxythymidine {[18F]-FLT} as a
tracer for positron emission tomography (PET) in a murine model of B-cell lymphoma and in …

Recently, the thymidine analog 3′-deoxy-3′-18F-fluorothymidine (FLT) was suggested for
imaging tumoral proliferation. In this prospective study, we examined whether 18F-FLT …

6-18F-fluoro-l-dopa (18F-FDOPA) measured with PET as a biomarker of amino acid uptake
has been investigated in brain tumor imaging. The aims of the current study were to …

We evaluated the amino acid and glucose metabolism of brain tumors by using PET with 3,
4-dihydroxy-6-18F-fluoro-l-phenylalanine (18F-FDOPA) and 18F-FDG. Methods: Eighty-one …

The aim of this study was to assess the clinical value of O-(2-18F-fluoroethyl)-l-tyrosine (18F-
FET) PET in the initial diagnosis of cerebral lesions suggestive of glioma. Methods: In a …